PMID- 34737242 OWN - NLM STAT- MEDLINE DCOM- 20220414 LR - 20220428 IS - 2005-1212 (Electronic) IS - 1976-2283 (Print) IS - 1976-2283 (Linking) VI - 16 IP - 2 DP - 2022 Mar 15 TI - Potential Role of Heme Oxygenase-1 in the Resolution of Experimentally Induced Colitis through Regulation of Macrophage Polarization. PG - 246-258 LID - 10.5009/gnl210058 [doi] AB - BACKGROUND/AIMS: Heme oxygenase-1 (HO-1) plays a central role in cellular defense against inflammatory insults, and its induction in macrophages potentiates their efferocytic activity. In this study, we explored the potential role of macrophage HO-1 in the resolution of experimentally induced colitis. METHODS: To induce colitis, male C57BL/6 mice were treated with 2% dextran sulfate sodium (DSS) in the drinking water for 7 days. To investigate efferocytosis, apoptotic colon epithelial CCD 841 CoN cells were coincubated with bone marrow-derived macrophages (BMDMs). RESULTS: Administration of the HO-1 inhibitor zinc protoporphyrin IX (ZnPP) blunted the resolution of DSS-induced intestinal inflammation and expression of the proresolving M2 macrophage marker CD206. BMDMs treated with apoptotic colonic epithelial cells showed significantly elevated expression of HO-1 and its regulator Nrf2. Under the same experimental conditions, the proportion of CD206-expressing macrophages was also enhanced. ZnPP treatment abrogated the upregulation of CD206 expression in BMDMs engulfing apoptotic colonic epithelial cells. This result was verified with BMDMs isolated from HO-1-knockout mice. BMDMs, when stimulated with lipopolysaccharide, exhibited increased expression of CD86, a marker of M1 macrophages. Coculture of lipopolysaccharide-stimulated BMDMs with apoptotic colonic epithelial cell debris dampened the expression of CD86 as well as the pro-inflammatory cytokines in an HO-1-dependent manner. Genetic ablation as well as pharmacologic inhibition of HO-1 significantly reduced the proportion of efferocytic BMDMs expressing the scavenger receptor CD36. CONCLUSIONS: HO-1 plays a key role in the resolution of experimentally induced colitis by modulating the polarization of macrophages. FAU - Gwak, Shin-Young AU - Gwak SY AUID- ORCID: 0000-0002-8988-7087 AD - Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul, Korea. FAU - Kim, Su-Jung AU - Kim SJ AUID- ORCID: 0000-0002-3636-0644 AD - Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul, Korea. FAU - Park, Jeongmin AU - Park J AUID- ORCID: 0000-0002-3243-7800 AD - Department of Biological Sciences, University of Ulsan, Ulsan, Korea. FAU - Kim, Seung Hyeon AU - Kim SH AUID- ORCID: 0000-0002-9359-7517 AD - Cancer Research Institute, Seoul National University, Seoul, Korea. FAU - Joe, Yeonsoo AU - Joe Y AUID- ORCID: 0000-0001-8407-8902 AD - Department of Biological Sciences, University of Ulsan, Ulsan, Korea. FAU - Lee, Ha-Na AU - Lee HN AUID- ORCID: 0000-0001-5063-6689 AD - Laboratory of Immunology, Division of Biotechnology Review and Research-III, Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD. FAU - Kim, Wonki AU - Kim W AUID- ORCID: 0000-0003-0339-7675 AD - Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul, Korea. FAU - Muna, Ishrat Aklima AU - Muna IA AUID- ORCID: 0000-0003-4384-1611 AD - Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul, Korea. FAU - Na, Hye-Kyung AU - Na HK AUID- ORCID: 0000-0003-0460-2810 AD - Department of Food Science and Biotechnology, College of Knowledge-Based Services Engineering, Sungshin Women's University, Seoul, Korea. FAU - Chung, Hun Taeg AU - Chung HT AUID- ORCID: 0000-0003-4802-7467 AD - Department of Biological Sciences, University of Ulsan, Ulsan, Korea. FAU - Surh, Young-Joon AU - Surh YJ AUID- ORCID: 0000-0001-8310-1795 AD - Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul, Korea. AD - Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul, Korea. AD - Cancer Research Institute, Seoul National University, Seoul, Korea. LA - eng PT - Journal Article PL - Korea (South) TA - Gut Liver JT - Gut and liver JID - 101316452 RN - 0 (Lipopolysaccharides) RN - 9042-14-2 (Dextran Sulfate) RN - EC 1.14.14.18 (Heme Oxygenase-1) SB - IM MH - Animals MH - *Colitis/chemically induced/drug therapy MH - Dextran Sulfate MH - *Heme Oxygenase-1 MH - Humans MH - Lipopolysaccharides/adverse effects/metabolism MH - Macrophages/metabolism MH - Male MH - Mice MH - Mice, Inbred C57BL PMC - PMC8924814 OTO - NOTNLM OT - Acute colitis OT - Dextran sulfate sodium OT - Efferocytosis OT - Macrophage polarization OT - Resolution of inflammation COIS- CONFLICTS OF INTEREST No potential conflict of interest relevant to this article was reported. EDAT- 2021/11/06 06:00 MHDA- 2022/04/15 06:00 PMCR- 2021/11/05 CRDT- 2021/11/05 06:04 PHST- 2021/02/05 00:00 [received] PHST- 2021/05/20 00:00 [revised] PHST- 2021/05/24 00:00 [accepted] PHST- 2021/11/06 06:00 [pubmed] PHST- 2022/04/15 06:00 [medline] PHST- 2021/11/05 06:04 [entrez] PHST- 2021/11/05 00:00 [pmc-release] AID - gnl210058 [pii] AID - gnl-16-2-246 [pii] AID - 10.5009/gnl210058 [doi] PST - ppublish SO - Gut Liver. 2022 Mar 15;16(2):246-258. doi: 10.5009/gnl210058.